RSV prevention protects preemies' lungs for many years

June 03, 2002

A short-term treatment to prevent RSV infection in premature infants with lung disease provided significant respiratory and immunologic benefits up to 10 years later, according to researchers at National Jewish Medical and Research Center, the University of Colorado Health Sciences Center and The Children's Hospital in Denver. The findings, published in the June issue of The American Journal of Medicine, lend support to the hypothesis that respiratory syncytial virus (RSV) can contribute to the development of asthma.

"Preventing these premature infants from contracting an RSV infection during their first winter had long-term benefits for their health," said Sally Wenzel, M.D., co-author and Professor of Medicine at National Jewish. "They have better lung function, and fewer colds, asthma attacks and allergies."

The children in the study were infants born 10 to 11 weeks prematurely, who spent weeks in intensive care and on ventilators. Their compromised lungs made them especially susceptible to infection with RSV, a common childhood illness. In healthy children, RSV usually develops into a relatively harmless upper respiratory infection. But in vulnerable children, such as these premature infants, the RSV infection is more likely to become a serious infection of the lungs. Thirteen of the children in the current study received monthly injections during their first winter of an immune globulin preparation with antibodies to RSV. The short-term trial showed that the preparation was effective at preventing RSV infection.

RSV infection of the lower respiratory tract has also been associated with the development of asthma. Dr. Wenzel and Eric Simoes, M.D., Professor of Pediatrics, Section of Infectious Diseases, at The Children's Hospital, decided to follow as many children from the original trial as possible to learn the long-term effects of RSV prevention in the first year of life. Seven to 10 years after the original trials, they found 13 of the 29 who had received the RSV preventive treatment. They compared them to 26 similar children, also premature infants with lung disease, who had not received the RSV preventive treatment. More then 80% (21/26) of the control group had had RSV infections of their lower respiratory tracts, compared to 15% (2/13) of the children who had received the immune globulin.

The children who received the RSV prevention had significantly less airway obstruction and better airway conductance. In one measure of general lung function, 85% (11/13) of the children who received the treatment had normal lung function compared to only 38% (9/26) of the control group. Children in the control group had an average of three colds in the previous year versus one for the RSV prevention group.

Children in the RSV prevention group had fewer asthma attacks and used less asthma medication in the previous year than did the control-group children. Children in the control group had an average of one asthma attack in the previous year, while those in the RSV prevention group had an average of none. Seventy percent (18/26) of the control children used an asthma medication in the previous year, compared to 40% (5/13) in the RSV prevention group. A smaller percentage of the children in the RSV prevention group were diagnosed with asthma, although the difference was not statistically significant.

"The children who received the RSV prevention are clearly healthier," said Dr. Wenzel. "Difficulty finding many of the children from the original study limited the size of our study sample and the statistical power of our study. But the consistency of the results, from lung function to colds to use of asthma medications makes me believe that RSV infection in the first year of life can contribute to the development of asthma."

One statistic especially favorable to the RSV/asthma connection is the higher rate of allergy among the control group. Allergies are more common among asthmatics and in many cases can trigger an asthma attack. Half (13/26) the control group of children demonstrated an allergy to one of 10 common allergens in the Denver area, while only 15% (2/13) of the RSV prevention group displayed any allergies.

"While this small study is not adequate to generally recommend preventive measures for RSV in the prevention of asthma, it strongly supports that approach in infants with underlying lung disease," said Dr. Simoes. Dr Simoes is involved in a large-scale European trial to determine whether prevention of RSV in premature infants can prevent subsequent asthma.
-end-


National Jewish Health

Related Asthma Articles from Brightsurf:

Breastfeeding and risks of allergies and asthma
In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.

Researchers make asthma breakthrough
Researchers from Trinity College Dublin have made a breakthrough that may eventually lead to improved therapeutic options for people living with asthma.

Physics vs. asthma
A research team from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases has collaborated with colleagues from the U.S., Canada, France, and Germany to determine the spatial structure of the CysLT1 receptor.

New knowledge on the development of asthma
Researchers at Karolinska Institutet in Sweden have studied which genes are expressed in overactive immune cells in mice with asthma-like inflammation of the airways.

Eating fish may help prevent asthma
A scientist from James Cook University in Australia says an innovative study has revealed new evidence that eating fish can help prevent asthma.

Academic performance of urban children with asthma worse than peers without asthma
A new study published in Annals of Allergy, Asthma and Immunology shows urban children with poorly controlled asthma, particularly those who are ethnic minorities, also suffer academically.

Asthma Controller Step Down Yardstick -- treatment guidance for when asthma improves
The focus for asthma treatment is often stepping up treatment, but clinicians need to know how to step down therapy when symptoms improve.

Asthma management tools improve asthma control and reduce hospital visits
A set of comprehensive asthma management tools helps decrease asthma-related visits to the emergency department, urgent care or hospital and improves patients' asthma control.

Asthma linked to infertility but not among women taking regular asthma preventers
Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to research published in the European Respiratory Journal.

What are the best ways to diagnose and manage asthma?
A team of experts from The University of Texas Medical Branch at Galveston examined the current information available from many different sources on diagnosing and managing mild to moderate asthma in adults and summarized them.

Read More: Asthma News and Asthma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.